banner Click here for the Ovarian Cancer Center of Excellence Home Page Click here for the UC Irvine Health Home Page Click here for the UC Irvine Home Page

2017 Cytoreductive Surgery Conference

Surf & Sand Resort, Laguna Beach, Calif.UC Irvine School of Medicine invites you to attend our annual conference on cytoreductive surgery for ovarian cancer and peritoneal malignancies in fall 2017.

The three-day conference — led by Dr. Robert E. Bristow, director of the UC Irvine Health Ovarian Cancer Center and chair of the Department of Obstetrics & Gynecology — will feature internationally recognized guest speakers.

What: "Advanced Course in Cytoreductive Surgery for Ovarian Cancer and Peritoneal Surface Malignancies: Radical Pelvic and Upper Abdominal Procedure with Cadaver Dissection"

When: Oct. 19-21, 2017

Where: Surf & Sand Resort, 1555 South Coast Highway, Laguna Beach, CA 92651

Special discounted hotel room rates on the beach are available for conference attendees, however early booking is advised because space is limited. We recommend making travel arrangements early. A room rate of $295 a night is guaranteed for conference attendees through Sept. 6, 2017.

Contact the hotel directly for reservations at 800-837-9230. Be sure to state that you are attending the UC Irvine Health course in Cytoreductive Surgery. All attendees are responsible for their own reservations. The resort's standard individual reservation cancellation policy will apply.

Course Fees:

  • $1,950.00 — Physicians
  • $1,450.00 — Fellows and residents (limited to the first eight applicants) Sold out.

The course fee includes both days of the conference, the evening reception, continental breakfast, lunch and CME certificate.

2017 Course Directors

UC Irvine faculty course directors for the conference are:

View the 2017 course agenda ›

Guest Faculty

Our internationally recognized guest faculty are:

  • Ahmed N. Al-Niaimi, MD
    University of Wisconsin School of Medicine and Public Health, Madison, WI
  • Dennis S. Chi, MD
    Memorial Sloan Kettering Cancer Center, New York City, NY
  • William A. Cliby, MD
    Mayo Clinic, Rochester, MN
  • Marcela G. del Carmen, MD, MPH
    Harvard Medical School and Massachusetts General Hospital, Boston, MA
  • Scott M. Eisenkop, MD
    Women’s Cancer Center of Southern California, Los Angeles, CA
  • Ramez N. Eskander, MD
    University of California, San Diego, San Diego, CA
  • Christina Fotopoulou, MD, PhD
    Imperial College of London Healthcare NHS Trust, Queen Charlotte's and Chelsea Hospital, London, United Kingdom
  • C. William Helm, MBBCh
    Northern Gynaecological Oncology Centre, Newcastle upon Tyne, United Kingdom
  • Jula Veerapong, MD
    University of California, San Diego, San Diego, CA
  • Oliver Zivanovic, MD, PhD
    Memorial Sloan Kettering Cancer Center, New York City, NY

Purpose of the Course:
The thoroughness of cytoreductive surgery is a primary contributor to survival for patients with advanced ovarian and primary peritoneal carcinoma. This program is designed to provide information through formal lectures, panel discussions and cadaver dissection about clinical applications of advanced cytoreductive surgery for ovarian cancer and related gynecologic peritoneal surface malignancies.

Target Audience: This activity is designed for physicians and surgeons who practice the specialty of gynecologic oncology and surgical oncology.

Learning Objectives: After completing the learning activity, the participant should be able to:

  • Describe the prognostic impact of minimal residual disease achievable through advanced cytoreductive surgical procedures.
  • Discuss the advantages, limitations and indications for advanced cytoreductive surgery in gynecological practice.
  • Describe the critical steps in performing advanced cytoreductive surgical procedures in gynecology

Accreditation Statement: The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide medical education for physicians.

Designation Statement: The University of California, Irvine School of Medicine designates this live activity of a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in this activity.

Disclosure Statement: It is the policy for the University of California, Irvine School of Medicine and University of California CME consortium to ensure balance, independence, objectivity and scientific rigor in all CME activities. Full disclosure of conflict and resolution will be made in writing via handout materials or syllabus.

California Assembly Bill 1195: This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit the CME website at

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your needs. For any special requests, please contact Jenille Powers at 714-456-5968 or on or before Sept. 15, 2017.